No connection

Search Results

TNONW

BEARISH
$0.01 Live
Tenon Medical, Inc. · NASDAQ
$0.01 52W Range $0.01
Overview AI Snowflake Price Valuation Profitability Growth Health Statements Ownership SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 21, 2026
Market cap
N/A
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
Tenon Medical (TNONW) exhibits extreme financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating severe failures in profitability, liquidity, and operational efficiency. While the company reported a Q/Q revenue growth of 92.34%, this is insufficient to offset the lack of fundamental stability and a stagnant share price of $0.01. The absence of an Altman Z-Score and most valuation metrics suggests a company with minimal transparency or viability. The current Price/Book ratio of 0.04 is likely a signal of impaired assets rather than an undervalued opportunity.

Key Strengths

Significant Q/Q revenue growth (92.34%)
Maintains current SEC filing compliance
Extremely low entry price for speculative traders
Low Price-to-Book ratio (0.04)
Recent 10-K filing indicates ongoing corporate existence

Key Risks

Extreme bankruptcy risk indicated by Piotroski F-Score of 1/9
Lack of institutional ownership and analyst coverage
Severe liquidity constraints and lack of cash flow data
Penny stock volatility and potential for delisting
Bearish technical trend (0/100)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
13
Weak
Value
20
Future
30
Past
10
Health
5
Dividend
0
AI Verdict
Distressed Asset
Key drivers: Critical Piotroski F-Score, Stagnant $0.01 share price, Absence of fundamental financial data
Confidence
90%
Value
20/100

P/B of 0.04 suggests the market values the company far below its book value, typical of distressed firms.

Positives
  • Very low Price/Book ratio
Watchpoints
  • No P/E or PEG available
  • Graham Number unavailable
Future
30/100

Revenue growth is the only positive metric, but it is not translating to equity value.

Positives
  • Strong Q/Q revenue growth
Watchpoints
  • No earnings growth data
  • No clear path to profitability
Past
10/100

Historical price action shows a complete lack of momentum.

Positives
  • Marginal 5Y change (+10.2%)
Watchpoints
  • Flat price performance over 1M and 1W
  • Long-term stagnation at $0.01
Health
5/100

A Piotroski score of 1/9 is a strong deterministic signal of financial instability.

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score of 1/9
  • Missing Altman Z-Score
Dividend
0/100

Dividend strength is 0/100.

Positives
No standout positives identified.
Watchpoints
  • No dividend yield
  • No payout history

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.01

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for TNONW and closest competitors.

Updated 2026-04-20
TNO
Tenon Medical, Inc.
Primary
5Y
+10.2%
3Y
+10.2%
1Y
+10.2%
6M
+10.2%
1M
0.0%
1W
0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
0.04
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth +92.34%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
68.7%
Op. Margin
-193.5%
Net Margin
-191.2%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
1.13x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
109%

Ownership Structure

Institutional and insider holdings breakdown

Ownership Breakdown

Top Institutional Holders

Spectrum Asset Management, Inc. (NB/CA)
679,420 shares • 2025-12-31
Clear Street Group Inc.
952,794 shares • 2025-12-31
Focus Partners Wealth
61,887 shares • 2025-12-31
Gts Securities LLC
21,044 shares • 2025-12-31
Heights Capital Management, Inc
140,236 shares • 2025-12-31
Armistice Capital, LLC
22,250 shares • 2025-12-31
Citadel Advisors Llc
71,533 shares • 2025-12-31
Virtu Financial LLC
14,651 shares • 2025-12-31

SEC Filings

Recent regulatory filings from the SEC EDGAR database

10-K
ANNUAL REPORT
2026-03-27

TNONW filed its 10-K annual report on March 27, 2026, which includes standard sections for business operations, risk factors, and management's discussion and analysis. The provided excerpts contain the filing's structure but do not include specific financial metrics or detailed risk descriptions.

8-K
CURRENT REPORT
2026-03-19

TNONW filed a Current Report on March 19, 2026, likely announcing its annual financial results for the preceding fiscal year.

8-K
CURRENT REPORT
2026-03-17
8-K
CURRENT REPORT
2026-02-27

TNONW filed a current report on February 27, 2026, likely to announce its annual financial results or quarterly earnings.

8-K
CURRENT REPORT
2026-02-06
8-K
CURRENT REPORT
2025-11-17
10-Q
QUARTERLY REPORT
2025-11-13

TNONW filed its Form 10-Q quarterly report on November 13, 2025. While the filing includes a section for risk factors under Item 1A, no specific financial highlights or detailed risk descriptions were provided in the available excerpts.

8-K/A
AMENDMENT NO. 1 TO FORM 8-K
2025-10-17

TNONW filed an amendment to a previously submitted Form 8-K on October 17, 2025.

8-K
CURRENT REPORT
2025-10-16

TNONW filed a current report on October 16, 2025, likely announcing its third-quarter financial results.

8-K
CURRENT REPORT
2025-09-23

TNONW filed a Current Report on September 23, 2025, to disclose a material event.

10-Q
QUARTERLY REPORT
2025-08-13
8-K
CURRENT REPORT
2025-08-07
DEF 14A
DEFINITIVE PROXY STATEMENT
2025-06-17
10-Q
QUARTERLY REPORT
2025-05-13
S-1
REGISTRATION STATEMENT
2025-04-04
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning TNONW from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile